Department of Pharmacology, The University of Texas Health Science Center at San Antonio.
Research Service, South Texas Veterans Health Care System, San Antonio, Texas.
Behav Pharmacol. 2021 Aug 1;32(5):357-367. doi: 10.1097/FBP.0000000000000624.
The 3,4-methylenedioxypyrovalerone (MDPV), and other structurally related synthetic cathinones, are popular alternatives to prototypical illicit psychostimulants, such as cocaine and methamphetamine. These drugs are often referred to as 'bath salts' and function either as cocaine-like inhibitors of monoamine uptake, or amphetamine-like substrates for dopamine, norepinephrine and serotonin transporters. These studies used male Sprague-Dawley rats trained to discriminate MDPV from saline to evaluate the substitution profiles of structurally related synthetic cathinones, cocaine, and other direct-acting dopamine and noradrenergic receptor agonists in order to characterize the relative contributions of dopamine, norepinephrine and serotonin to the discriminative stimulus effects of MDPV. As expected, each of the cathinones and cocaine dose-dependently increased MDPV-appropriate responding, with a rank-order potency that was positively correlated with their potency to inhibit dopamine and norepinephrine, but not serotonin, a relationship that is consistent with the rank order to maintain self-administration. The dopamine D2/3 receptor-preferring agonist quinpirole produced a modest increase in MDPV-appropriate responding, whereas the dopamine D1/5 receptor agonist, SKF 82958, nonselective dopamine receptor agonist, apomorphine, as well as the α-1, and α-2 adrenergic receptor agonists, phenylephrine and clonidine, respectively, failed to increase MDPV-appropriate responding at doses smaller than those that suppressed responding altogether. Although these studies do not support a role for serotonergic or adrenergic systems in mediating/modulating the discriminative stimulus effects of MDPV, convergent evidence is provided to suggest that the discriminative stimulus effects of MDPV are primarily mediated by its capacity to inhibit dopamine uptake, and the subsequent activation of dopamine D2 or D3 receptors.
3,4-亚甲二氧基吡咯戊酮(MDPV)和其他结构相关的合成苯丙胺类兴奋剂是经典非法兴奋剂如可卡因和甲基苯丙胺的流行替代品。这些药物通常被称为“浴盐”,其作用机制或是可卡因样单胺摄取抑制剂,或是安非他命样多巴胺、去甲肾上腺素和 5-羟色胺转运体的底物。这些研究使用雄性 Sprague-Dawley 大鼠进行训练,使其能够区分 MDPV 和盐水,以评估结构相关的合成苯丙胺类兴奋剂、可卡因和其他直接作用的多巴胺和去甲肾上腺素能受体激动剂的替代谱,从而确定多巴胺、去甲肾上腺素和 5-羟色胺对 MDPV 辨别刺激效应的相对贡献。正如预期的那样,每种苯丙胺类兴奋剂和可卡因都剂量依赖性地增加了 MDPV 恰当反应,其效力顺序与它们抑制多巴胺和去甲肾上腺素的效力呈正相关,但与 5-羟色胺无关,这种关系与维持自我给药的效力顺序一致。多巴胺 D2/3 受体偏好激动剂喹吡罗仅引起 MDPV 恰当反应的适度增加,而多巴胺 D1/5 受体激动剂 SKF 82958、非选择性多巴胺受体激动剂阿扑吗啡,以及α-1 和α-2 肾上腺素能受体激动剂,分别为苯肾上腺素和可乐定,在低于完全抑制反应的剂量下,未能增加 MDPV 恰当反应。虽然这些研究不支持 5-羟色胺能或肾上腺素能系统在介导/调节 MDPV 辨别刺激效应中的作用,但提供了一致的证据表明,MDPV 的辨别刺激效应主要由其抑制多巴胺摄取的能力以及随后激活多巴胺 D2 或 D3 受体介导。